Methoxamine
From Wikipedia, the free encyclopedia
Not to be confused with methoxetamine.
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
2-amino-1-(2,5-dimethoxyphenyl)propan-1-ol
|
|
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Identifiers | |
| CAS Number | 390-28-3  |
| ATC code | C01CA10 |
| PubChem | CID 6082 |
| IUPHAR/BPS | 483 |
| DrugBank | DB00723  |
| ChemSpider | 5857 |
| UNII | HUQ1KC1YLI |
| KEGG | D08201 |
| ChEMBL | CHEMBL524 |
| Chemical data | |
| Formula | C11H17NO3 |
| Molar mass | 211.258 |
|
|
|
|
| (what is this?) (verify) |
Methoxamine is an α1-adrenergic receptor agonist,[1] similar in structure to phenylephrine and 2,5-DMA. It was developed by Burroughs-Wellcome in the 1940s.[2] The drug induces vasoconstriction of skin and splanchnic blood vessels, thereby increasing peripheral vascular resistance and raising mean arterial blood pressure. Because of its hypertensive effects, it may evoke a compensatory reflex bradycardia via the baroreceptors.
See also[edit]
References[edit]
- ^ Pazdernik, Thomas L.; Kerecsen, Laszlo (2007) [2003]. "5". In Goljan, Edward F. Pharmacology (Paperback). Rapid Review (Second ed.). Philadelphia, PA: Mosby-Elsevier. p. 39. ISBN 978-0-323-04550-6.
- ^ US Patent 2359707 - DIMETHOXYPHENYL beta-HYDROXY ISOPROPYLAMINE
|
|
|
|
 |
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
 |
This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |
